Global Radiopharmaceuticals Market Research Report 2025(Status and Outlook)
Report Overview
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report provides a deep insight into the global Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceuticals market in any manner.
Global Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segmentation (by Type)
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals Market
Overview of the regional outlook of the Radiopharmaceuticals Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
This report provides a deep insight into the global Radiopharmaceuticals market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceuticals Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceuticals market in any manner.
Global Radiopharmaceuticals Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segmentation (by Type)
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals Market
Overview of the regional outlook of the Radiopharmaceuticals Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals Segment by Type
1.2.2 Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals Product Life Cycle
3.3 Global Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.8 Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL RADIOPHARMACEUTICALS MARKET BY REGION
6.1 Global Radiopharmaceuticals Market Size by Region
6.1.1 Global Radiopharmaceuticals Market Size by Region
6.1.2 Global Radiopharmaceuticals Market Size Market Share by Region
6.2 Global Radiopharmaceuticals Sales by Region
6.2.1 Global Radiopharmaceuticals Sales by Region
6.2.2 Global Radiopharmaceuticals Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Radiopharmaceuticals Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Radiopharmaceuticals Market Size by Type
7.3 North America Radiopharmaceuticals Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Radiopharmaceuticals Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Radiopharmaceuticals Market Size by Type
8.3 Europe Radiopharmaceuticals Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Radiopharmaceuticals Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Radiopharmaceuticals Market Size by Type
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Radiopharmaceuticals Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Radiopharmaceuticals Market Size by Type
10.3 South America Radiopharmaceuticals Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Radiopharmaceuticals Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Radiopharmaceuticals Market Size by Type
11.3 Middle East and Africa Radiopharmaceuticals Market Size by Application
12 RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
12.1 Global Production of Radiopharmaceuticals by Region(2020-2025)
12.2 Global Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
12.3 Global Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Radiopharmaceuticals Production
12.4.1 North America Radiopharmaceuticals Production Growth Rate (2020-2025)
12.4.2 North America Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Radiopharmaceuticals Production
12.5.1 Europe Radiopharmaceuticals Production Growth Rate (2020-2025)
12.5.2 Europe Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Radiopharmaceuticals Production (2020-2025)
12.6.1 Japan Radiopharmaceuticals Production Growth Rate (2020-2025)
12.6.2 Japan Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Radiopharmaceuticals Production (2020-2025)
12.7.1 China Radiopharmaceuticals Production Growth Rate (2020-2025)
12.7.2 China Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
13 RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Radiopharmaceuticals Sales Market Share by Type (2020-2033)
13.3 Global Radiopharmaceuticals Market Size Market Share by Type (2020-2033)
13.4 Global Radiopharmaceuticals Price by Type (2020-2033)
14 RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Radiopharmaceuticals Market Sales by Application (2020-2033)
14.3 Global Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
14.4 Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Bracco Imaging
15.1.1 Bracco Imaging Basic Information
15.1.2 Bracco Imaging Radiopharmaceuticals Product Overview
15.1.3 Bracco Imaging Radiopharmaceuticals Product Market Performance
15.1.4 Bracco Imaging Business Overview
15.1.5 Bracco Imaging SWOT Analysis
15.1.6 Bracco Imaging Recent Developments
15.2 Bayer
15.2.1 Bayer Basic Information
15.2.2 Bayer Radiopharmaceuticals Product Overview
15.2.3 Bayer Radiopharmaceuticals Product Market Performance
15.2.4 Bayer Business Overview
15.2.5 Bayer SWOT Analysis
15.2.6 Bayer Recent Developments
15.3 Mallinckrodt
15.3.1 Mallinckrodt Basic Information
15.3.2 Mallinckrodt Radiopharmaceuticals Product Overview
15.3.3 Mallinckrodt Radiopharmaceuticals Product Market Performance
15.3.4 Mallinckrodt Business Overview
15.3.5 Mallinckrodt SWOT Analysis
15.3.6 Mallinckrodt Recent Developments
15.4 Nordion
15.4.1 Nordion Basic Information
15.4.2 Nordion Radiopharmaceuticals Product Overview
15.4.3 Nordion Radiopharmaceuticals Product Market Performance
15.4.4 Nordion Business Overview
15.4.5 Nordion Recent Developments
15.5 Triad Isotopes
15.5.1 Triad Isotopes Basic Information
15.5.2 Triad Isotopes Radiopharmaceuticals Product Overview
15.5.3 Triad Isotopes Radiopharmaceuticals Product Market Performance
15.5.4 Triad Isotopes Business Overview
15.5.5 Triad Isotopes Recent Developments
15.6 Lantheus
15.6.1 Lantheus Basic Information
15.6.2 Lantheus Radiopharmaceuticals Product Overview
15.6.3 Lantheus Radiopharmaceuticals Product Market Performance
15.6.4 Lantheus Business Overview
15.6.5 Lantheus Recent Developments
15.7 IBA Group
15.7.1 IBA Group Basic Information
15.7.2 IBA Group Radiopharmaceuticals Product Overview
15.7.3 IBA Group Radiopharmaceuticals Product Market Performance
15.7.4 IBA Group Business Overview
15.7.5 IBA Group Recent Developments
15.8 GE Healthcare
15.8.1 GE Healthcare Basic Information
15.8.2 GE Healthcare Radiopharmaceuticals Product Overview
15.8.3 GE Healthcare Radiopharmaceuticals Product Market Performance
15.8.4 GE Healthcare Business Overview
15.8.5 GE Healthcare Recent Developments
15.9 China Isotope and Radiation
15.9.1 China Isotope and Radiation Basic Information
15.9.2 China Isotope and Radiation Radiopharmaceuticals Product Overview
15.9.3 China Isotope and Radiation Radiopharmaceuticals Product Market Performance
15.9.4 China Isotope and Radiation Business Overview
15.9.5 China Isotope and Radiation Recent Developments
15.10 Jubilant Pharma
15.10.1 Jubilant Pharma Basic Information
15.10.2 Jubilant Pharma Radiopharmaceuticals Product Overview
15.10.3 Jubilant Pharma Radiopharmaceuticals Product Market Performance
15.10.4 Jubilant Pharma Business Overview
15.10.5 Jubilant Pharma Recent Developments
15.11 Eli Lilly
15.11.1 Eli Lilly Basic Information
15.11.2 Eli Lilly Radiopharmaceuticals Product Overview
15.11.3 Eli Lilly Radiopharmaceuticals Product Market Performance
15.11.4 Eli Lilly Business Overview
15.11.5 Eli Lilly Recent Developments
15.12 Advanced Accelerator Applications
15.12.1 Advanced Accelerator Applications Basic Information
15.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Overview
15.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product Market Performance
15.12.4 Advanced Accelerator Applications Business Overview
15.12.5 Advanced Accelerator Applications Recent Developments
15.13 SIEMENS
15.13.1 SIEMENS Basic Information
15.13.2 SIEMENS Radiopharmaceuticals Product Overview
15.13.3 SIEMENS Radiopharmaceuticals Product Market Performance
15.13.4 SIEMENS Business Overview
15.13.5 SIEMENS Recent Developments
15.14 Dongcheng
15.14.1 Dongcheng Basic Information
15.14.2 Dongcheng Radiopharmaceuticals Product Overview
15.14.3 Dongcheng Radiopharmaceuticals Product Market Performance
15.14.4 Dongcheng Business Overview
15.14.5 Dongcheng Recent Developments
15.15 Navidea
15.15.1 Navidea Basic Information
15.15.2 Navidea Radiopharmaceuticals Product Overview
15.15.3 Navidea Radiopharmaceuticals Product Market Performance
15.15.4 Navidea Business Overview
15.15.5 Navidea Recent Developments
16 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals Segment by Type
1.2.2 Radiopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Radiopharmaceuticals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLOBAL RADIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals Product Life Cycle
3.3 Global Radiopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
3.8 Radiopharmaceuticals Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Radiopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 GLOBAL RADIOPHARMACEUTICALS MARKET BY REGION
6.1 Global Radiopharmaceuticals Market Size by Region
6.1.1 Global Radiopharmaceuticals Market Size by Region
6.1.2 Global Radiopharmaceuticals Market Size Market Share by Region
6.2 Global Radiopharmaceuticals Sales by Region
6.2.1 Global Radiopharmaceuticals Sales by Region
6.2.2 Global Radiopharmaceuticals Sales Market Share by Region
7 NORTH AMERICA MARKET OVERVIEW
7.1 North America Radiopharmaceuticals Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Radiopharmaceuticals Market Size by Type
7.3 North America Radiopharmaceuticals Market Size by Application
8 EUROPE MARKET OVERVIEW
8.1 Europe Radiopharmaceuticals Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Radiopharmaceuticals Market Size by Type
8.3 Europe Radiopharmaceuticals Market Size by Application
9 ASIA-PACIFIC MARKET OVERVIEW
9.1 Asia-Pacific Radiopharmaceuticals Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Radiopharmaceuticals Market Size by Type
9.3 Asia-Pacific Radiopharmaceuticals Market Size by Application
10 SOUTH AMERICA MARKET OVERVIEW
10.1 South America Radiopharmaceuticals Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Radiopharmaceuticals Market Size by Type
10.3 South America Radiopharmaceuticals Market Size by Application
11 MIDDLE EAST AND AFRICA MARKET OVERVIEW
11.1 Middle East and Africa Radiopharmaceuticals Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Radiopharmaceuticals Market Size by Type
11.3 Middle East and Africa Radiopharmaceuticals Market Size by Application
12 RADIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
12.1 Global Production of Radiopharmaceuticals by Region(2020-2025)
12.2 Global Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
12.3 Global Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Radiopharmaceuticals Production
12.4.1 North America Radiopharmaceuticals Production Growth Rate (2020-2025)
12.4.2 North America Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Radiopharmaceuticals Production
12.5.1 Europe Radiopharmaceuticals Production Growth Rate (2020-2025)
12.5.2 Europe Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Radiopharmaceuticals Production (2020-2025)
12.6.1 Japan Radiopharmaceuticals Production Growth Rate (2020-2025)
12.6.2 Japan Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Radiopharmaceuticals Production (2020-2025)
12.7.1 China Radiopharmaceuticals Production Growth Rate (2020-2025)
12.7.2 China Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
13 RADIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Radiopharmaceuticals Sales Market Share by Type (2020-2033)
13.3 Global Radiopharmaceuticals Market Size Market Share by Type (2020-2033)
13.4 Global Radiopharmaceuticals Price by Type (2020-2033)
14 RADIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Radiopharmaceuticals Market Sales by Application (2020-2033)
14.3 Global Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
14.4 Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
15 KEY COMPANIES PROFILE
15.1 Bracco Imaging
15.1.1 Bracco Imaging Basic Information
15.1.2 Bracco Imaging Radiopharmaceuticals Product Overview
15.1.3 Bracco Imaging Radiopharmaceuticals Product Market Performance
15.1.4 Bracco Imaging Business Overview
15.1.5 Bracco Imaging SWOT Analysis
15.1.6 Bracco Imaging Recent Developments
15.2 Bayer
15.2.1 Bayer Basic Information
15.2.2 Bayer Radiopharmaceuticals Product Overview
15.2.3 Bayer Radiopharmaceuticals Product Market Performance
15.2.4 Bayer Business Overview
15.2.5 Bayer SWOT Analysis
15.2.6 Bayer Recent Developments
15.3 Mallinckrodt
15.3.1 Mallinckrodt Basic Information
15.3.2 Mallinckrodt Radiopharmaceuticals Product Overview
15.3.3 Mallinckrodt Radiopharmaceuticals Product Market Performance
15.3.4 Mallinckrodt Business Overview
15.3.5 Mallinckrodt SWOT Analysis
15.3.6 Mallinckrodt Recent Developments
15.4 Nordion
15.4.1 Nordion Basic Information
15.4.2 Nordion Radiopharmaceuticals Product Overview
15.4.3 Nordion Radiopharmaceuticals Product Market Performance
15.4.4 Nordion Business Overview
15.4.5 Nordion Recent Developments
15.5 Triad Isotopes
15.5.1 Triad Isotopes Basic Information
15.5.2 Triad Isotopes Radiopharmaceuticals Product Overview
15.5.3 Triad Isotopes Radiopharmaceuticals Product Market Performance
15.5.4 Triad Isotopes Business Overview
15.5.5 Triad Isotopes Recent Developments
15.6 Lantheus
15.6.1 Lantheus Basic Information
15.6.2 Lantheus Radiopharmaceuticals Product Overview
15.6.3 Lantheus Radiopharmaceuticals Product Market Performance
15.6.4 Lantheus Business Overview
15.6.5 Lantheus Recent Developments
15.7 IBA Group
15.7.1 IBA Group Basic Information
15.7.2 IBA Group Radiopharmaceuticals Product Overview
15.7.3 IBA Group Radiopharmaceuticals Product Market Performance
15.7.4 IBA Group Business Overview
15.7.5 IBA Group Recent Developments
15.8 GE Healthcare
15.8.1 GE Healthcare Basic Information
15.8.2 GE Healthcare Radiopharmaceuticals Product Overview
15.8.3 GE Healthcare Radiopharmaceuticals Product Market Performance
15.8.4 GE Healthcare Business Overview
15.8.5 GE Healthcare Recent Developments
15.9 China Isotope and Radiation
15.9.1 China Isotope and Radiation Basic Information
15.9.2 China Isotope and Radiation Radiopharmaceuticals Product Overview
15.9.3 China Isotope and Radiation Radiopharmaceuticals Product Market Performance
15.9.4 China Isotope and Radiation Business Overview
15.9.5 China Isotope and Radiation Recent Developments
15.10 Jubilant Pharma
15.10.1 Jubilant Pharma Basic Information
15.10.2 Jubilant Pharma Radiopharmaceuticals Product Overview
15.10.3 Jubilant Pharma Radiopharmaceuticals Product Market Performance
15.10.4 Jubilant Pharma Business Overview
15.10.5 Jubilant Pharma Recent Developments
15.11 Eli Lilly
15.11.1 Eli Lilly Basic Information
15.11.2 Eli Lilly Radiopharmaceuticals Product Overview
15.11.3 Eli Lilly Radiopharmaceuticals Product Market Performance
15.11.4 Eli Lilly Business Overview
15.11.5 Eli Lilly Recent Developments
15.12 Advanced Accelerator Applications
15.12.1 Advanced Accelerator Applications Basic Information
15.12.2 Advanced Accelerator Applications Radiopharmaceuticals Product Overview
15.12.3 Advanced Accelerator Applications Radiopharmaceuticals Product Market Performance
15.12.4 Advanced Accelerator Applications Business Overview
15.12.5 Advanced Accelerator Applications Recent Developments
15.13 SIEMENS
15.13.1 SIEMENS Basic Information
15.13.2 SIEMENS Radiopharmaceuticals Product Overview
15.13.3 SIEMENS Radiopharmaceuticals Product Market Performance
15.13.4 SIEMENS Business Overview
15.13.5 SIEMENS Recent Developments
15.14 Dongcheng
15.14.1 Dongcheng Basic Information
15.14.2 Dongcheng Radiopharmaceuticals Product Overview
15.14.3 Dongcheng Radiopharmaceuticals Product Market Performance
15.14.4 Dongcheng Business Overview
15.14.5 Dongcheng Recent Developments
15.15 Navidea
15.15.1 Navidea Basic Information
15.15.2 Navidea Radiopharmaceuticals Product Overview
15.15.3 Navidea Radiopharmaceuticals Product Market Performance
15.15.4 Navidea Business Overview
15.15.5 Navidea Recent Developments
16 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Radiopharmaceuticals Market Size by Application (M USD)
Table 5. Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2024)
Table 11. Global Market Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Radiopharmaceuticals Manufacturing Sites and Area Served
Table 13. Manufacturers Radiopharmaceuticals Product Type
Table 14. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 26. Global Radiopharmaceuticals Market Size by Region (2020-2033) & (M USD)
Table 27. Global Radiopharmaceuticals Market Size Market Share by Region (2020-2033)
Table 28. Global Radiopharmaceuticals Sales by Region (2020-2033) & (K MT)
Table 29. Global Radiopharmaceuticals Sales Market Share by Region (2020-2033)
Table 30. North America Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 31. North America Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 32. North America Radiopharmaceuticals Sales by Type (K MT)
Table 33. North America Radiopharmaceuticals Market Size by Type (M USD)
Table 34. North America Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 35. North America Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 36. North America Radiopharmaceuticals Sales by Application (K MT)
Table 37. North America Radiopharmaceuticals Market Size by Application (M USD)
Table 38. North America Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 39. North America Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 40. Europe Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 42. Europe Radiopharmaceuticals Sales by Type (K MT)
Table 43. Europe Radiopharmaceuticals Market Size by Type (M USD)
Table 44. Europe Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 45. Europe Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 46. Europe Radiopharmaceuticals Sales by Application (K MT)
Table 47. Europe Radiopharmaceuticals Market Size by Application (M USD)
Table 48. Europe Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 49. Europe Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Radiopharmaceuticals Sales by Type (K MT)
Table 53. Asia-Pacific Radiopharmaceuticals Market Size by Type (M USD)
Table 54. Asia-Pacific Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Radiopharmaceuticals Sales by Application (K MT)
Table 57. Asia-Pacific Radiopharmaceuticals Market Size by Application (M USD)
Table 58. Asia-Pacific Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
Table 60. South America Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 61. South America Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 62. South America Radiopharmaceuticals Sales by Type (K MT)
Table 63. South America Radiopharmaceuticals Market Size by Type (M USD)
Table 64. South America Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 65. South America Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 66. South America Radiopharmaceuticals Sales by Application (K MT)
Table 67. South America Radiopharmaceuticals Market Size by Application (M USD)
Table 68. South America Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 69. South America Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Radiopharmaceuticals Sales by Type (K MT)
Table 73. Middle East and Africa Radiopharmaceuticals Market Size by Type (M USD)
Table 74. Middle East and Africa Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Radiopharmaceuticals Sales by Application (K MT)
Table 77. Middle East and Africa Radiopharmaceuticals Market Size by Application (M USD)
Table 78. Middle East and Africa Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 80. Global Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 81. Global Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 83. Global Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Radiopharmaceuticals Sales by Type (K MT)
Table 89. Global Radiopharmaceuticals Market Size by Type (M USD)
Table 90. Global Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 91. Global Radiopharmaceuticals Sales Market Share by Type (2020-2033)
Table 92. Global Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 93. Global Radiopharmaceuticals Market Size Share by Type (2020-2033)
Table 94. Global Radiopharmaceuticals Sales (K MT) by Application
Table 95. Global Radiopharmaceuticals Market Size by Application(M USD)
Table 96. Global Radiopharmaceuticals Sales by Application (2020-2033) & (K MT)
Table 97. Global Radiopharmaceuticals Sales Market Share by Application (2020-2033)
Table 98. Global Radiopharmaceuticals Market Size by Application (2020-2033) & (M USD)
Table 99. Global Radiopharmaceuticals Market Share by Application (2020-2033)
Table 100. Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
Table 101. Bracco Imaging Basic Information
Table 102. Bracco Imaging Radiopharmaceuticals Product Overview
Table 103. Bracco Imaging Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Bracco Imaging Business Overview
Table 105. Bracco Imaging SWOT Analysis
Table 106. Bracco Imaging Recent Developments
Table 107. Bayer Basic Information
Table 108. Bayer Radiopharmaceuticals Product Overview
Table 109. Bayer Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Bayer Business Overview
Table 111. Bayer SWOT Analysis
Table 112. Bayer Recent Developments
Table 113. Mallinckrodt Basic Information
Table 114. Mallinckrodt Radiopharmaceuticals Product Overview
Table 115. Mallinckrodt Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Mallinckrodt Business Overview
Table 117. Mallinckrodt SWOT Analysis
Table 118. Mallinckrodt Recent Developments
Table 119. Nordion Basic Information
Table 120. Nordion Radiopharmaceuticals Product Overview
Table 121. Nordion Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Nordion Business Overview
Table 123. Nordion Recent Developments
Table 124. Triad Isotopes Basic Information
Table 125. Triad Isotopes Radiopharmaceuticals Product Overview
Table 126. Triad Isotopes Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Triad Isotopes Business Overview
Table 128. Triad Isotopes Recent Developments
Table 129. Lantheus Basic Information
Table 130. Lantheus Radiopharmaceuticals Product Overview
Table 131. Lantheus Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Lantheus Business Overview
Table 133. Lantheus Recent Developments
Table 134. IBA Group Basic Information
Table 135. IBA Group Radiopharmaceuticals Product Overview
Table 136. IBA Group Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. IBA Group Business Overview
Table 138. IBA Group Recent Developments
Table 139. GE Healthcare Basic Information
Table 140. GE Healthcare Radiopharmaceuticals Product Overview
Table 141. GE Healthcare Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. GE Healthcare Business Overview
Table 143. GE Healthcare Recent Developments
Table 144. China Isotope and Radiation Basic Information
Table 145. China Isotope and Radiation Radiopharmaceuticals Product Overview
Table 146. China Isotope and Radiation Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. China Isotope and Radiation Business Overview
Table 148. China Isotope and Radiation Recent Developments
Table 149. Jubilant Pharma Basic Information
Table 150. Jubilant Pharma Radiopharmaceuticals Product Overview
Table 151. Jubilant Pharma Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Jubilant Pharma Business Overview
Table 153. Jubilant Pharma Recent Developments
Table 154. Eli Lilly Basic Information
Table 155. Eli Lilly Radiopharmaceuticals Product Overview
Table 156. Eli Lilly Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Eli Lilly Business Overview
Table 158. Eli Lilly Recent Developments
Table 159. Advanced Accelerator Applications Basic Information
Table 160. Advanced Accelerator Applications Radiopharmaceuticals Product Overview
Table 161. Advanced Accelerator Applications Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Advanced Accelerator Applications Business Overview
Table 163. Advanced Accelerator Applications Recent Developments
Table 164. SIEMENS Basic Information
Table 165. SIEMENS Radiopharmaceuticals Product Overview
Table 166. SIEMENS Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. SIEMENS Business Overview
Table 168. SIEMENS Recent Developments
Table 169. Dongcheng Basic Information
Table 170. Dongcheng Radiopharmaceuticals Product Overview
Table 171. Dongcheng Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Dongcheng Business Overview
Table 173. Dongcheng Recent Developments
Table 174. Navidea Basic Information
Table 175. Navidea Radiopharmaceuticals Product Overview
Table 176. Navidea Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Navidea Business Overview
Table 178. Navidea Recent Developments
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceuticals Market Size by Type (M USD)
Table 4. Global Radiopharmaceuticals Market Size by Application (M USD)
Table 5. Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2024)
Table 11. Global Market Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Radiopharmaceuticals Manufacturing Sites and Area Served
Table 13. Manufacturers Radiopharmaceuticals Product Type
Table 14. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Radiopharmaceuticals Market Size Comparison by Region (M USD)
Table 26. Global Radiopharmaceuticals Market Size by Region (2020-2033) & (M USD)
Table 27. Global Radiopharmaceuticals Market Size Market Share by Region (2020-2033)
Table 28. Global Radiopharmaceuticals Sales by Region (2020-2033) & (K MT)
Table 29. Global Radiopharmaceuticals Sales Market Share by Region (2020-2033)
Table 30. North America Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 31. North America Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 32. North America Radiopharmaceuticals Sales by Type (K MT)
Table 33. North America Radiopharmaceuticals Market Size by Type (M USD)
Table 34. North America Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 35. North America Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 36. North America Radiopharmaceuticals Sales by Application (K MT)
Table 37. North America Radiopharmaceuticals Market Size by Application (M USD)
Table 38. North America Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 39. North America Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 40. Europe Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 42. Europe Radiopharmaceuticals Sales by Type (K MT)
Table 43. Europe Radiopharmaceuticals Market Size by Type (M USD)
Table 44. Europe Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 45. Europe Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 46. Europe Radiopharmaceuticals Sales by Application (K MT)
Table 47. Europe Radiopharmaceuticals Market Size by Application (M USD)
Table 48. Europe Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 49. Europe Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Radiopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Radiopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Radiopharmaceuticals Sales by Type (K MT)
Table 53. Asia-Pacific Radiopharmaceuticals Market Size by Type (M USD)
Table 54. Asia-Pacific Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Radiopharmaceuticals Sales by Application (K MT)
Table 57. Asia-Pacific Radiopharmaceuticals Market Size by Application (M USD)
Table 58. Asia-Pacific Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
Table 60. South America Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 61. South America Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 62. South America Radiopharmaceuticals Sales by Type (K MT)
Table 63. South America Radiopharmaceuticals Market Size by Type (M USD)
Table 64. South America Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 65. South America Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 66. South America Radiopharmaceuticals Sales by Application (K MT)
Table 67. South America Radiopharmaceuticals Market Size by Application (M USD)
Table 68. South America Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 69. South America Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Radiopharmaceuticals Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Radiopharmaceuticals Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Radiopharmaceuticals Sales by Type (K MT)
Table 73. Middle East and Africa Radiopharmaceuticals Market Size by Type (M USD)
Table 74. Middle East and Africa Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Radiopharmaceuticals Sales by Application (K MT)
Table 77. Middle East and Africa Radiopharmaceuticals Market Size by Application (M USD)
Table 78. Middle East and Africa Radiopharmaceuticals Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Application (2020-2033)
Table 80. Global Radiopharmaceuticals Production (K MT) by Region(2020-2025)
Table 81. Global Radiopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 83. Global Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Radiopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Radiopharmaceuticals Sales by Type (K MT)
Table 89. Global Radiopharmaceuticals Market Size by Type (M USD)
Table 90. Global Radiopharmaceuticals Sales (K MT) by Type (2020-2033)
Table 91. Global Radiopharmaceuticals Sales Market Share by Type (2020-2033)
Table 92. Global Radiopharmaceuticals Market Size (M USD) by Type (2020-2033)
Table 93. Global Radiopharmaceuticals Market Size Share by Type (2020-2033)
Table 94. Global Radiopharmaceuticals Sales (K MT) by Application
Table 95. Global Radiopharmaceuticals Market Size by Application(M USD)
Table 96. Global Radiopharmaceuticals Sales by Application (2020-2033) & (K MT)
Table 97. Global Radiopharmaceuticals Sales Market Share by Application (2020-2033)
Table 98. Global Radiopharmaceuticals Market Size by Application (2020-2033) & (M USD)
Table 99. Global Radiopharmaceuticals Market Share by Application (2020-2033)
Table 100. Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
Table 101. Bracco Imaging Basic Information
Table 102. Bracco Imaging Radiopharmaceuticals Product Overview
Table 103. Bracco Imaging Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Bracco Imaging Business Overview
Table 105. Bracco Imaging SWOT Analysis
Table 106. Bracco Imaging Recent Developments
Table 107. Bayer Basic Information
Table 108. Bayer Radiopharmaceuticals Product Overview
Table 109. Bayer Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Bayer Business Overview
Table 111. Bayer SWOT Analysis
Table 112. Bayer Recent Developments
Table 113. Mallinckrodt Basic Information
Table 114. Mallinckrodt Radiopharmaceuticals Product Overview
Table 115. Mallinckrodt Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Mallinckrodt Business Overview
Table 117. Mallinckrodt SWOT Analysis
Table 118. Mallinckrodt Recent Developments
Table 119. Nordion Basic Information
Table 120. Nordion Radiopharmaceuticals Product Overview
Table 121. Nordion Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Nordion Business Overview
Table 123. Nordion Recent Developments
Table 124. Triad Isotopes Basic Information
Table 125. Triad Isotopes Radiopharmaceuticals Product Overview
Table 126. Triad Isotopes Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Triad Isotopes Business Overview
Table 128. Triad Isotopes Recent Developments
Table 129. Lantheus Basic Information
Table 130. Lantheus Radiopharmaceuticals Product Overview
Table 131. Lantheus Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Lantheus Business Overview
Table 133. Lantheus Recent Developments
Table 134. IBA Group Basic Information
Table 135. IBA Group Radiopharmaceuticals Product Overview
Table 136. IBA Group Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. IBA Group Business Overview
Table 138. IBA Group Recent Developments
Table 139. GE Healthcare Basic Information
Table 140. GE Healthcare Radiopharmaceuticals Product Overview
Table 141. GE Healthcare Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. GE Healthcare Business Overview
Table 143. GE Healthcare Recent Developments
Table 144. China Isotope and Radiation Basic Information
Table 145. China Isotope and Radiation Radiopharmaceuticals Product Overview
Table 146. China Isotope and Radiation Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. China Isotope and Radiation Business Overview
Table 148. China Isotope and Radiation Recent Developments
Table 149. Jubilant Pharma Basic Information
Table 150. Jubilant Pharma Radiopharmaceuticals Product Overview
Table 151. Jubilant Pharma Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Jubilant Pharma Business Overview
Table 153. Jubilant Pharma Recent Developments
Table 154. Eli Lilly Basic Information
Table 155. Eli Lilly Radiopharmaceuticals Product Overview
Table 156. Eli Lilly Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Eli Lilly Business Overview
Table 158. Eli Lilly Recent Developments
Table 159. Advanced Accelerator Applications Basic Information
Table 160. Advanced Accelerator Applications Radiopharmaceuticals Product Overview
Table 161. Advanced Accelerator Applications Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Advanced Accelerator Applications Business Overview
Table 163. Advanced Accelerator Applications Recent Developments
Table 164. SIEMENS Basic Information
Table 165. SIEMENS Radiopharmaceuticals Product Overview
Table 166. SIEMENS Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. SIEMENS Business Overview
Table 168. SIEMENS Recent Developments
Table 169. Dongcheng Basic Information
Table 170. Dongcheng Radiopharmaceuticals Product Overview
Table 171. Dongcheng Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Dongcheng Business Overview
Table 173. Dongcheng Recent Developments
Table 174. Navidea Basic Information
Table 175. Navidea Radiopharmaceuticals Product Overview
Table 176. Navidea Radiopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. Navidea Business Overview
Table 178. Navidea Recent Developments
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals Product Life Cycle
Figure 13. Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Radiopharmaceuticals
Figure 19. Global Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Radiopharmaceuticals Market Size by Region
Figure 27. Global Radiopharmaceuticals Market Size Market Share by Region (2020-2033)
Figure 28. Global Radiopharmaceuticals Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Radiopharmaceuticals Market Size (M USD) by Country
Figure 33. USA Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Radiopharmaceuticals Market Size (M USD)by Type
Figure 40. North America Radiopharmaceuticals Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Radiopharmaceuticals Market Size (M USD) by Country
Figure 45. Germany Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Radiopharmaceuticals Market Size (M USD) by Type
Figure 56. Europe Radiopharmaceuticals Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Country
Figure 61. China Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Type
Figure 72. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Radiopharmaceuticals Market Size (M USD) by Country
Figure 77. Brazil Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Radiopharmaceuticals Market Size (M USD) by Type
Figure 84. South America Radiopharmaceuticals Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Country
Figure 89. Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Type
Figure 100. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Application
Figure 101. Global Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 102. North America Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. China Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Radiopharmaceuticals Market Size by Type (M USD)
Figure 108. Sales Market Share of Radiopharmaceuticals by Type (2020-2033)
Figure 109. Sales Market Share of Radiopharmaceuticals by Type in 2024
Figure 110. Market Size Share of Radiopharmaceuticals by Type (2020-2033)
Figure 111. Market Size Share of Radiopharmaceuticals by Type in 2024
Figure 112. Global Radiopharmaceuticals Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Radiopharmaceuticals Market Size by Application(M USD)
Figure 115. Global Radiopharmaceuticals Market Share by Application
Figure 116. Global Radiopharmaceuticals Sales Market Share by Application (2020-2033)
Figure 117. Global Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 118. Global Radiopharmaceuticals Market Share by Application (2020-2033)
Figure 119. Global Radiopharmaceuticals Market Share by Application in 2024
Figure 120. Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
Figure 1. Product Picture of Radiopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals Market Size (M USD), 2024-2033
Figure 5. Global Radiopharmaceuticals Market Size (M USD) (2020-2033)
Figure 6. Global Radiopharmaceuticals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals Product Life Cycle
Figure 13. Radiopharmaceuticals Sales Share by Manufacturers in 2024
Figure 14. Global Radiopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 15. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Radiopharmaceuticals Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals Revenue in 2024
Figure 18. Industry Chain Map of Radiopharmaceuticals
Figure 19. Global Radiopharmaceuticals Market PEST Analysis
Figure 20. Global Radiopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Radiopharmaceuticals Market Size by Region
Figure 27. Global Radiopharmaceuticals Market Size Market Share by Region (2020-2033)
Figure 28. Global Radiopharmaceuticals Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Radiopharmaceuticals Market Size (M USD) by Country
Figure 33. USA Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Radiopharmaceuticals Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Radiopharmaceuticals Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Radiopharmaceuticals Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Radiopharmaceuticals Market Size (M USD)by Type
Figure 40. North America Radiopharmaceuticals Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Radiopharmaceuticals Market Size (M USD) by Country
Figure 45. Germany Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Radiopharmaceuticals Market Size (M USD) by Type
Figure 56. Europe Radiopharmaceuticals Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Country
Figure 61. China Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Radiopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Type
Figure 72. Asia-Pacific Radiopharmaceuticals Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Radiopharmaceuticals Market Size (M USD) by Country
Figure 77. Brazil Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Radiopharmaceuticals Market Size (M USD) by Type
Figure 84. South America Radiopharmaceuticals Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Country
Figure 89. Saudi Arabia Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Radiopharmaceuticals Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Radiopharmaceuticals Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Type
Figure 100. Middle East and Africa Radiopharmaceuticals Market Size (M USD) by Application
Figure 101. Global Radiopharmaceuticals Production Market Share by Region (2020-2025)
Figure 102. North America Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. China Radiopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Radiopharmaceuticals Market Size by Type (M USD)
Figure 108. Sales Market Share of Radiopharmaceuticals by Type (2020-2033)
Figure 109. Sales Market Share of Radiopharmaceuticals by Type in 2024
Figure 110. Market Size Share of Radiopharmaceuticals by Type (2020-2033)
Figure 111. Market Size Share of Radiopharmaceuticals by Type in 2024
Figure 112. Global Radiopharmaceuticals Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Radiopharmaceuticals Market Size by Application(M USD)
Figure 115. Global Radiopharmaceuticals Market Share by Application
Figure 116. Global Radiopharmaceuticals Sales Market Share by Application (2020-2033)
Figure 117. Global Radiopharmaceuticals Sales Market Share by Application in 2024
Figure 118. Global Radiopharmaceuticals Market Share by Application (2020-2033)
Figure 119. Global Radiopharmaceuticals Market Share by Application in 2024
Figure 120. Global Radiopharmaceuticals Sales Growth Rate by Application (2020-2033)
